| abstract |
The invention relates to pharmaceutical compositions used for the prevention or treatment of amyloid diseases, including Alzheimer's disease, prion diseases, familial amyloid neuropathies and the like. Pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, in particular fibril-forming peptides or proteins. The invention also relates to pharmaceutical compositions and methods using immune reagents that react with such fibril components. |